|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
2
|
Zenith Epigenetics
|
Mar 10, 2020 08:53PM
|
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
2
|
Zenith Epigenetics
|
Apr 19, 2020 01:41PM
|
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
2
|
Zenith Epigenetics
|
Apr 19, 2020 01:55PM
|
|
Re: AACR virtual meeting June22nd
|
4
|
Zenith Epigenetics
|
May 17, 2020 07:43AM
|
|
Re: AACR virtual meeting June22nd
|
|
Zenith Epigenetics
|
May 18, 2020 09:29AM
|
|
Re: AAIC and MD&A
|
4
|
Resverlogix Corp.
|
Jul 25, 2018 12:42AM
|
|
Re: AAIC and MD&A
|
8
|
Resverlogix Corp.
|
Jul 25, 2018 09:38AM
|
|
Re: AAIC and MD&A
|
3
|
Resverlogix Corp.
|
Jul 25, 2018 08:29PM
|
|
Re: ABCA1 overexpression worsens colorectal cancer prognosis and this can be ameliorated by apabetalone
|
5
|
Resverlogix Corp.
|
Aug 14, 2018 11:04AM
|
|
Re: aberaterone
|
5
|
Zenith Epigenetics
|
Jun 25, 2018 12:12PM
|
|
Re: aberaterone
|
3
|
Zenith Epigenetics
|
Jun 24, 2018 04:00PM
|
|
Re: ABL- COVID-19 Therapeutic
|
5
|
Resverlogix Corp.
|
Mar 07, 2021 10:22AM
|
|
Re: About that 18% to 21% RRR...
|
4
|
Resverlogix Corp.
|
Nov 20, 2019 09:52PM
|
|
Re: About that stroke failure
|
1
|
Resverlogix Corp.
|
Dec 13, 2019 11:23AM
|
|
Re: About that stroke failure
|
5
|
Resverlogix Corp.
|
Dec 13, 2019 01:35PM
|
|
Re: About that stroke failure
|
4
|
Resverlogix Corp.
|
Dec 13, 2019 01:52PM
|
|
Re: About that stroke failure
|
1
|
Resverlogix Corp.
|
Dec 13, 2019 07:54PM
|
|
Re: About the Monday Presentation
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 08:20AM
|
|
Re: Abstract - first example of a "curative" effect?
|
4
|
Resverlogix Corp.
|
Oct 11, 2018 08:27AM
|
|
Re: Abstract up
|
4
|
Resverlogix Corp.
|
Mar 17, 2020 11:51PM
|
